Home » Topics » Regulatory

Regulatory
RSS

Avandia label broadened in the U.S.

March 4, 2003

FDA approves Oxytrol for overactive bladder

March 3, 2003

Risperdal Consta approved in Spain

Feb. 28, 2003

FDA approval for Gliadel Wafer during initial surgery for primary malignant glioma

Feb. 28, 2003

Abilify sNDA submitted for long-term treatment of schizophrenia

Feb. 27, 2003

Approval sought for once-daily Reminyl

Feb. 27, 2003

Label for Botox widened in Europe

Feb. 27, 2003

Viread recommended for approval in E.U. for use in treatment-naive HIV patients

Feb. 26, 2003

CPMP recommends approval of Remicade for ankylosing spondylitis, label expansion

Feb. 26, 2003

Metformin XT NDA accepted for filing by FDA

Feb. 24, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...